Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Closing the loop on the bone-resorbing osteoclast

Nature Medicine volume 22, pages 460–461 (2016)Cite this article

Subjects

A new study shows in mice that tumor necrosis factor (TNF) superfamily member 11 (TNFSF11, also known as RANKL), which stimulates osteoclasts to remove bone, binds to the G-protein-coupled receptor LGR4 to prevent excessive bone removal. In mouse models of osteoporosis, a recombinant LGR4 ectodomain reduces bone loss.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The osteoclast negative-feedback loop.

References

  1. Häusler, K.D. et al. J. Bone Miner. Res. 19, 1873–1881 (2004).

    Article  Google Scholar 

  2. Luo, J. et al. Nat. Med 22, 539–546 (2016).

    Article  CAS  Google Scholar 

  3. Luo, J. et al. Development 136, 2747–2756 (2009).

    Article  CAS  Google Scholar 

  4. Sun, L. et al. Cell 125, 247–260 (2006).

    Article  CAS  Google Scholar 

  5. Abe, E. et al. Cell 115, 151–162 (2003).

    Article  CAS  Google Scholar 

  6. Ferlin, A., Pepe, A., Facciolli, A., Gianesello, L. & Foresta, C. Bone 46, 504–513 (2010).

    Article  CAS  Google Scholar 

  7. Yi, H., Wang, J., Kavallaris, M. & Yingzi-Wang, J. Blood 122, abstr. 887 (2013).

  8. Hur, E.M. & Zhou, F.Q. Nat. Rev. Neurosci. 11, 539–551 (2010).

    Article  CAS  Google Scholar 

  9. Li, Z., Zhang, W. & Mulholland, M.W. Front. Endocrinol. (Lausanne) 6, 131 (2015).

    PubMed Central  Google Scholar 

  10. Wu, C. et al. Nat. Commun. 5, 3149 (2014).

    Article  Google Scholar 

  11. Krausova, M. & Korinek, V. Cell. Signal. 26, 570–579 (2014).

    Article  CAS  Google Scholar 

  12. Du, B. et al. J. Biol. Chem. 288, 15131–15141 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mone Zaidi is in the Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, New York, New York, USA.,

    Mone Zaidi

  2. Jameel Iqbal is in the Department of Pathology, Los Angeles VA Medical Center, Los Angeles, California, USA.,

    Jameel Iqbal

Authors
  1. Mone Zaidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jameel Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mone Zaidi.

Ethics declarations

Competing interests

Mone Zaidi has consulted and/or consults for Merck, Novartis, Roche, Alexion, Gershon Lehman Group and Guidepoint on issues related to osteoporosis and its treatment. A patent relating to the effects of follicle-stimulating hormone on bone has been granted, and any proceeds to the Icahn School of Medicine at Mount Sinai from licensing or royalty will be shared with Dr. Zaidi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaidi, M., Iqbal, J. Closing the loop on the bone-resorbing osteoclast. Nat Med 22, 460–461 (2016). https://doi.org/10.1038/nm.4104

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4104

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing